Skip to main content
SpringerLink
Log in

Percutaneous Renal Surgery for Renal Pelvic Tumors: Overcoming the Difficulties

  • Chapter
  • First Online:
Difficult Cases in Endourology

  • 973 Accesses

Abstract

Upper tract transitional cell carcinoma accounts for roughly 5 % of all urothelial malignancies. Tumors of the renal collecting system and ureter rarely remain clinically silent. Most patients present with either hematuria and/or flank pain. A variety of diagnostic approaches may be utilized; however, computed tomography urography is currently the most sensitive and specific imaging modality. Urinary cytology continues to be important because of its sensitivity for high-grade lesions. Ureteroscopy has both a diagnostic and therapeutic role. Although ureteroscopic biopsies rarely provide accurate staging, multiple studies have demonstrated the strong correlation between tumor grade and stage.

Percutaneous resection of collecting system tumors has traditionally been reserved for patients with a solitary kidney, bilateral tumors, renal insufficiency, or significant medical comorbidities. Multiple series have demonstrated a low recurrence rate (approximately 20 %) in patients with low-grade disease. Recurrence and renal preservation rates are much less favorable for patients with high-grade tumors. Two studies have compared the efficacy of percutaneous resection to nephroureterectomy. Both found equivalent oncologic outcomes in patients with low-grade disease.

Percutaneous resection is well tolerated in the majority of patients. However, tract recurrences have been described in a few case reports. Therefore, it is imperative to ensure that the access sheath remains in the collecting system at all times to minimize tract exposure.

The efficacy of bacillus Calmette-Guerin adjuvant therapy has not been conclusively demonstrated. Nevertheless, most authors still recommend the use of adjuvant therapy given the absence of level one data.

Radical nephroureterectomy remains the treatment of choice for patients with high-grade disease who are surgical candidates. Elective percutaneous management should be considered in patients with low-grade disease given its equivalent oncologic efficacy, relative safety, and minimal impact on overall renal function.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Goodwin WE, Casey WC, Woolf W. Percutaneous trocar (needle) nephrostomy in hydronephrosis. J Am Med Assoc. 1955;157:891–4.

    Article  CAS  PubMed  Google Scholar 

  2. Fernstrom I, Johansson B. Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol. 1976;10:257–9.

    CAS  PubMed  Google Scholar 

  3. Smith AD, Orihuela E, Crowley AR. Percutaneous management of renal pelvic tumors: a treatment option in selected cases. J Urol. 1987;137:852–6.

    CAS  PubMed  Google Scholar 

  4. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–22.

    Article  PubMed  Google Scholar 

  5. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7–33.

    Article  CAS  PubMed  Google Scholar 

  6. Solsona E, Iborra I, Ricos JV, et al. Upper urinary tract involvement in patients with bladder carcinoma in situ (CIS): its impact on management. Urology. 1997;49:347–52.

    Article  CAS  PubMed  Google Scholar 

  7. Raman JD, Ng CK, Scherr DS, et al. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol. 2010;57:1072–9.

    Article  PubMed  Google Scholar 

  8. Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas. Eur Urol. 2011;59(4):584–94.

    Article  PubMed  Google Scholar 

  9. Guinan P, Vogelzang NJ, Randazzo R, et al. Renal pelvic cancer: a review of 611 patients treated in Illinois 1975–1985. Urology. 1992;40:393–9.

    Article  CAS  PubMed  Google Scholar 

  10. Wang LJ, Wong YC, Chuang CK, et al. Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria. J Urol. 2009;181:524–31.

    Article  PubMed  Google Scholar 

  11. Takahashi N, Kawashima A, Glockner JF, et al. Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography. Radiology. 2008;247:451–7.

    Article  PubMed  Google Scholar 

  12. Brown FM. Urine cytology. Is it still the gold standard for screening? Urol Clin North Am. 2000;27:25–37.

    Article  CAS  PubMed  Google Scholar 

  13. Guarnizo E, Pavlovich CP, Seiba M, et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol. 2000;163:52–5.

    Article  CAS  PubMed  Google Scholar 

  14. Keeley FX, Kulp DA, Bibbo M, et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol. 1997;157:42–3.

    Article  Google Scholar 

  15. Soderdahl DW, Fabrizio MD, Rahman NU, et al. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol. 2005;23:114–22.

    Article  PubMed  Google Scholar 

  16. Weight CJ, Larson BT, Fergany AF, et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol. 2010;183:1317–23.

    Article  PubMed  Google Scholar 

  17. National Kidney and Urological Diseases Information Clearinghouse, National Institute of Diabetes and Digestive and Kidney Disease (NIDDK). National Institutes of Health, NIH Publication 04-3895, Feb 2004.

    Google Scholar 

  18. Langner C, Hutterer G, Chromecki T, et al. pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Mod Pathol. 2006;19:272–9.

    Article  PubMed  Google Scholar 

  19. Jarrett TW, Sweetser PM, Weiss GH, et al. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J Urol. 1995;154:1629–35.

    Article  CAS  PubMed  Google Scholar 

  20. Plancke HR, Strijbos WE, Delaere KP. Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis. Br J Urol. 1995;75:736–9.

    Article  CAS  PubMed  Google Scholar 

  21. Patel A, Soonawalla P, Shepherd SF, et al. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J Urol. 1996;155:868–74.

    Article  CAS  PubMed  Google Scholar 

  22. Martinez-Pineiro JA, Garcia Matres MJ, Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol. 1996;156:377–85.

    Article  CAS  PubMed  Google Scholar 

  23. Clark PE, Streem SB, Geisinger MA. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol. 1999;161:772–5.

    Article  CAS  PubMed  Google Scholar 

  24. Jabbour ME, Smith AD. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am. 2000;27:739–50.

    Article  CAS  PubMed  Google Scholar 

  25. Jabbour ME, Desgrandchamps F, Cazin S, et al. Percutaneous management of grade II upper urinary tract transitional cell: the long-term outcome. J Urol. 2000;163:1105–7.

    Article  CAS  PubMed  Google Scholar 

  26. Liatsikos EN, Dinlenc CZ, Kapoor R, et al. Transitional cell carcinoma of the renal pelvis: ureteroscopic and percutaneous approach. J Endourol. 2001;15:377–83.

    Article  CAS  PubMed  Google Scholar 

  27. Elliott DS, Segura JW, Lightner D, et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology. 2001;58:174–8.

    Article  CAS  PubMed  Google Scholar 

  28. Deligne E, Colombel M, Badet L, et al. Conservative management of upper urinary tract tumors. Eur Urol. 2002;42:43–8.

    Article  PubMed  Google Scholar 

  29. Goel MC, Mahendra V, Roberts JG. Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol. 2003;169:925–9.

    Article  PubMed  Google Scholar 

  30. Palou J, Piovesan LF, Huguet J, et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol. 2004;172:66–9.

    Article  PubMed  Google Scholar 

  31. Rastinehad AR, Ost MC, Vanderbrink BA, et al. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy? Urology. 2009;73:27–31.

    Article  PubMed  Google Scholar 

  32. Lee BR, Jabbour ME, Marshall FF, et al. 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes. J Endourol. 1999;13:289–94.

    Article  CAS  PubMed  Google Scholar 

  33. Roupret M, Hupertan V, Traxer O, et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology. 2006;67:1181–7.

    Article  PubMed  Google Scholar 

  34. Oefelein MC, MacLennan G. Transitional cell carcinoma recurrence in the nephrostomy tract after percutaneous resection. J Urol. 2003;170:521.

    Article  PubMed  Google Scholar 

  35. Woodhouse CR, Kellett MJ, Bloom HJ. Percutaneous renal surgery and local radiotherapy in the management of renal pelvic transitional cell carcinoma. Br J Urol. 1986;58:245–9.

    Article  CAS  PubMed  Google Scholar 

  36. Sheperd SF, Patel A, Bidmead AM, et al. Nephrostomy track brachytherapy following percutaneous resection of transitional cell carcinoma of the renal pelvis. Clin Oncol. 1995;7:385–7.

    Article  Google Scholar 

  37. Irie A, Iwamura M, Kadowaki K, et al. Intravesical instillation of bacillus Calmette-Guerin for carcinoma in situ of the urothelium involving the upper urinary tract utilizing vesicoureteral reflux created by a double-pigtail catheter. Urology. 2002;59:53–7.

    Article  PubMed  Google Scholar 

  38. Sharpe JR, Duffy G, Chin JL. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J Urol. 1993;149:457–60.

    CAS  PubMed  Google Scholar 

  39. Thalmann GN, Markwalder R, Walter B, et al. Long term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol. 2002;168:1381–5.

    Article  PubMed  Google Scholar 

  40. Nishino Y, Yamamoto N, Komeda H, et al. Bacillus Calmette-Guerin instillation treatment for carcinoma in situ of the upper urinary tract. BJU Int. 2000;85:799–801.

    Article  CAS  PubMed  Google Scholar 

  41. Bellman GC, Sweetser P, Smith AD. Complications of intracavitary bacillus Calmette-Guerin after percutaneous resection of upper tract transitional cell carcinoma. J Urol. 1994;151:13–5.

    CAS  PubMed  Google Scholar 

  42. Chen GL, El-Gabry EA, Bagley DH. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology, and urinalysis. J Urol. 2000;164:1901–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Smith Institute for Urology, Hofstra North Shore – Long Island Jewish Health System, 450 Lakeville Road, New Hyde Park, NY, 11042, USA

    Brian Duty M.D., Michael Blute M.D., Zhamshid Okhunov M.D., Arthur D. Smith M.D. & Zeph Okeke M.D.

Authors
  1. Brian Duty M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Blute M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhamshid Okhunov M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arthur D. Smith M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zeph Okeke M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zeph Okeke M.D. .

Editor information

Editors and Affiliations

  1. Fac. Medicine, Dept. Surgery, Kuwait University, Safat, Kuwait

    Ahmed M. Al-Kandari

  2. , Department of Urology, Muljibhai Patel Urological Hospital, Dr Virendra Desai Road, Nadiad, 387 001, India

    Mahesh Desai

  3. , Urology and Nephrology Center, Mansoura University, Gomhoria Street, Mansoura, 35516, Egypt

    Ahmed A. Shokeir

  4. , Urology and Nephrology Center, Mansoura University, Gomhoria Street, Mansoura, 35516, Egypt

    Ahmed M. Shoma

  5. , Smith Institute for Urology, Long Island Jewish Health System, New York, 11040, USA

    Arthur D. Smith

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Duty, B., Blute, M., Okhunov, Z., Smith, A.D., Okeke, Z. (2013). Percutaneous Renal Surgery for Renal Pelvic Tumors: Overcoming the Difficulties. In: Al-Kandari, A., Desai, M., Shokeir, A., Shoma, A., Smith, A. (eds) Difficult Cases in Endourology. Springer, London. https://doi.org/10.1007/978-1-84882-083-8_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-083-8_11

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-082-1

  • Online ISBN: 978-1-84882-083-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation